Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
ARTICLE, Behavioral/Systems

GABAC Receptors Control Adaptive Changes in a Glycinergic Inhibitory Pathway in Salamander Retina

Paul B. Cook, Peter D. Lukasiewicz and John S. McReynolds
Journal of Neuroscience 15 January 2000, 20 (2) 806-812; https://doi.org/10.1523/JNEUROSCI.20-02-00806.2000
Paul B. Cook
1Department of Physiology, The University of Michigan, Ann Arbor, Michigan, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter D. Lukasiewicz
2Department of Ophthalmology and Visual Science, Washington University, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John S. McReynolds
1Department of Physiology, The University of Michigan, Ann Arbor, Michigan, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Effects of picrotoxin on inhibitory currents in ganglion cells. Responses are from an on–off ganglion cell in a tiger salamander slice preparation. The cell was voltage clamped at 0 mV to eliminate glutamate-mediated excitatory currents.A, IPSCs elicited by 4 sec full-field light stimuli (indicated by the horizontalbarbeloweachtrace).Traces show IPSCs recorded before application of picrotoxin (control) and 1, 2, and 9 min after onset of superfusion with picrotoxin (PTX 1′, 2′, and9′). Subsequent addition of 2 μmstrychnine in the continued presence of picrotoxin (PTX + STR) completely blocked the enhanced IPSCs, indicating that they were mediated by glycine. The holding current was +42 pA. The light flashes also elicited IPSCs at light off (data not shown); the effects on the off responses were similar to those of the on responses.B, Same as A, except that the IPSCs were evoked by zaps (+0.5 μA; 1 msec) in the outer plexiform layer directly above the recorded ganglion cell. The time of the zap stimulus is indicated by dotbelow each response.Inset,Right, Peak light-evoked (filledcircles) and zap-evoked (opencircles) IPSC amplitudes at additional times.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Enhancement of glycinergic IPSCs by picrotoxin is greater in dark- than light-adapted retinas. A, IPSCs elicited by full-field light flashes at different times after onset of continuous superfusion with picrotoxin. Data are averaged from 16 dark-adapted retinas (filledcircles) and 7 light-adapted retinas (opencircles). For each cell, peak IPSC amplitudes were normalized to that of the first response recorded in the presence of picrotoxin, which was recorded within 1 min after switching the superfusate to picrotoxin. Superfusion with picrotoxin begins at t = 0. In 11 of the cells tested (8 dark-adapted, 3 light-adapted) 2 μm strychnine was added after the enhancement had reached a maximum; in all cases strychnine completely blocked the IPSCs, indicating that they were glycinergic. Error bars indicate 1 SEM. The maximum enhancement was 3.57 (± 0.33)-fold in dark-adapted preparations (n = 16) and 1.49 (± 0.15)-fold in light-adapted preparations (n = 7). The probability that this difference was caused by chance was < 0.003 (Student's unpairedt test). B, Same as A, except that the IPSCs were elicited by focal electrical stimuli (+0.5 μA; 1 msec) as described in Figure 1. The maximum enhancement was 2.38 (± 0.20)-fold for dark-adapted preparations (n = 4) and 1.12 (± 0.28)-fold for light-adapted preparations (n = 4). The probability that this difference was caused by chance was < 0.001 (Student's unpaired t test). DA, Dark-adapted; LA, light-adapted.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Effect of picrotoxin on ganglion cell IPSCs in a light-adapted retinal slice. Left, Details in Figure 1, except that this retina had been light adapted by exposure to background illumination for several minutes. Inset,Right, Superimposed traces of the first two responses (control and PTX 1′) scaled to the same amplitude to better illustrate the difference in time courses.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Picrotoxin slowly enhances light-evoked glycinergic responses but rapidly blocks responses to directly applied GABA. Responses are IPSCs evoked by alternating full-field light flashes (opencircles) and puffs of GABA (filledcircles). Picrotoxin (PTX) rapidly blocked the responses to GABA puffs, but the light-evoked IPSCs were initially reduced and then slowly enhanced over the next 20 min. Similar results were seen in all of the four cells tested.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Bicuculline does not enhance glycinergic IPSCs in ganglion cells. A, Light-evoked IPSCs.Opencircles show the amplitude of IPSCs at various times after onset of continuous superfusion with 200 μm bicuculline (BIC). For comparison,filledcircles show the results (from Fig. 2A) obtained during superfusion with 150 μm picrotoxin (PTX). Data were averaged from 16 cells for PTX and 5 cells forBIC. For each cell, peak IPSC amplitudes were normalized to the first response recorded in the presence of picrotoxin.B, Same as A, except that the IPSCs were elicited by zaps (+0.5 μA; 1 msec) as described in Figure 1.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Effect of picrotoxin on excitatory currents in an on–off ganglion cell. The cell was voltage clamped at the chloride reversal potential (−65 mV) to eliminate GABA- and glycine-mediated inhibitory currents. Other details are as described in Figure 1.A, EPSCs that were elicited by 4 sec full-field light stimuli. After the onset of picrotoxin the EPSCs were initially enhanced (PTX 2′) but then gradually declined (PTX 17′). Subsequent addition of 2 μmstrychnine in the continued presence of picrotoxin (PTX + STR) partially reversed the slow decline in EPSC amplitude caused by picrotoxin, indicating that the slowly developing suppression of the EPSC was mediated by glycine. The holding current was −52 pA. The effects on the off responses (data not shown) were similar.B, Same as A, except that the EPSCs were elicited by zaps (+0.5 μA; 1 msec) as described in Figure 1.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Picrotoxin does not affect the ganglion cell response to direct application of glycine. Datapoints indicate the average peak amplitude of IPSCs elicited by full-field illumination (opencircles) and puffs of glycine (filledcircles) in four cells at various times after onset of continuous superfusion with picrotoxin att = 0. For each cell, responses were normalized to the first response after the application of picrotoxin in each cell.GLY, Glycine.

  • Fig. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Effect of dopamine and dopamine antagonists on the ability of picrotoxin to cause slow enhancement of glycinergic IPSCs. Light stimuli and recording conditions are as described in Figure 1.A, Addition of 20 μm dopamine caused a rapid increase in IPSC amplitude within 2 min (DOP 2′), but there was no further increase after 15 additional minutes in dopamine (DOP 17′). The initial enhancement of the IPSC by dopamine was seen in only two of the four cells tested; in all four cells the mean enhancement was 1.13 (± 0.32)-fold (p = 0.65). After 18 min in dopamine, addition of 150 μm picrotoxin caused an immediate strong reduction in the IPSC (DOP + PTX 2′). In the continued presence of PTX the IPSC was slowly enhanced (DOP + PTX 17′). The mean enhancement by PTX was 4.02 (± 1.48)-fold (p = 0.02;n = 4). B, Addition of 15 μm SCH23390 and 150 μmPTXcaused an immediate reduction of the IPSC (SCH + PTX 2′), but in the continued presence of PTX andSCH the response slowly became enhanced (SCH + PTX 17′). In the five cells tested, the maximum enhancement byPTX in the presence of SCH was 4.42 (± 1.24)-fold (p = 0.02). In bothA and B the enhanced IPSC inPTX was completely blocked by 2 μmstrychnine in all cells (data not shown).

  • Fig. 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 9.

    Effect of picrotoxin on transient lateral inhibition and glycinergic IPSPs in on–off ganglion cells in eyecup preparations. A, Effect of 150 μmpicrotoxin (PTX) on TLI in a dark-adapted eyecup. TLI was measured as the suppression of the response to a small test spot in the receptive field center by rotation of a broken annulus (windmill) pattern. B, Effect of picrotoxin on the transient IPSP elicited at the onset of an annulus (i.d., 500 μm; o.d., 2600 μm) in a light-adapted eyecup. Traces show the IPSP response in control Ringer's solution and at 2 and 10 min after onset of continuous superfusion with 150 μmpicrotoxin. The horizontallinebelow the responsetracesindicates the initial portion of the 4 sec light stimulus.

Back to top

In this issue

The Journal of Neuroscience: 20 (2)
Journal of Neuroscience
Vol. 20, Issue 2
15 Jan 2000
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
GABAC Receptors Control Adaptive Changes in a Glycinergic Inhibitory Pathway in Salamander Retina
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
GABAC Receptors Control Adaptive Changes in a Glycinergic Inhibitory Pathway in Salamander Retina
Paul B. Cook, Peter D. Lukasiewicz, John S. McReynolds
Journal of Neuroscience 15 January 2000, 20 (2) 806-812; DOI: 10.1523/JNEUROSCI.20-02-00806.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
GABAC Receptors Control Adaptive Changes in a Glycinergic Inhibitory Pathway in Salamander Retina
Paul B. Cook, Peter D. Lukasiewicz, John S. McReynolds
Journal of Neuroscience 15 January 2000, 20 (2) 806-812; DOI: 10.1523/JNEUROSCI.20-02-00806.2000
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • retina
  • adaptation
  • GABAC receptor
  • neuromodulator
  • glycine
  • salamander

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

ARTICLE

  • Scaffolding of Fyn Kinase to the NMDA Receptor Determines Brain Region Sensitivity to Ethanol
  • Cytoskeletal and Morphological Alterations Underlying Axonal Sprouting after Localized Transection of Cortical Neuron AxonsIn Vitro
  • Aberrant Chloride Transport Contributes to Anoxic/Ischemic White Matter Injury
Show more ARTICLE

Behavioral/Systems

  • Vocal Control Neuron Incorporation Decreases with Age in the Adult Zebra Finch
  • Modulation by Central and Basolateral Amygdalar Nuclei of Dopaminergic Correlates of Feeding to Satiety in the Rat Nucleus Accumbens and Medial Prefrontal Cortex
  • Interaction of Excitation and Inhibition in Anteroventral Cochlear Nucleus Neurons That Receive Large Endbulb Synaptic Endings
Show more Behavioral/Systems
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.